Zdeer Completes Over RMB 1 Billion in Funding Within Six Months to Accelerate Family Healthcare Innovation

VCBeat has learned that zdeer (hereinafter referred to as “zdeer”), a technology brand focused on home healthcare, has recently secured over RMB 100 million in financing.

This financing round follows three previous rounds of investment from firms including Tiantu Capital, Hillhouse Investment, Haiquan Fund, Qingliu Capital, CO-WIN Venture Capital, and Country Garden Ventures. Since then, zdeer has completed two additional rounds: an A++ round in early 2023, with follow-on investments from existing shareholders such as Tiantu Capital, CO-WIN Venture Capital, and Country Garden Ventures; and a Series B round in mid-2023, closed with CICC Huirong (under CICC Capital), totaling over RMB 100 million. Taihe Capital served as the exclusive financial advisor for this latest round.

It is reported that the funds from this financing round are planned to be invested in zdeer’s R&D, supply chain development, and channel expansion, further consolidating and expanding its industry influence in the tech-enabled healthcare sector.

Founded in 2014, zdeer has strategically positioned itself in the medical and general health sector through multi-category integration. Focusing on home healthcare, the company advocates the value proposition of “light, slow, and nurturing wellness,” offering solutions to address the public’s three major health needs: “wellness preservation,” “maintenance care,” and “therapeutic recuperation.”

Within six months, zdeer secured two rounds of capital infusion. What lies behind the strong interest from multiple investors?

Over a decade of accumulation, zdeer has remained steadfastly focused on home medical healthcare. Breaking through with its smart moxibustion box, the company has pioneered new frontiers in tech-driven medical care and healthy living. It continues to launch innovative tech-medical products, including smart hearing aids, sleep aids, rhinitis relief devices, and smart hair growth devices, as well as healthy-lifestyle products such as smart moxibustion systems, smart cupping and gua sha tools, smart oral sprays, and smart foot bath barrels. Through years of sustained investment in research and development, zdeer has secured invention patent portfolios for its core medical and health product lines, enabling continuous technological iteration and upgrades.

Taking hearing aids as an example, zdeer has maintained continuous R&D investment in technology over the past five years. To date, the company has filed more than 200 patent applications for hearing aids, including over 100 invention patents. Meanwhile, zdeer has achieved significant technological breakthroughs in bone-conduction hearing aids and secured multiple related invention patents.

Currently, zdeer has established two major product business segments: Technology-based Healthcare and Healthy Living. The Technology-based Healthcare segment focuses primarily on “treatment” within home settings, aiming to address significant health challenges faced by a smaller population (i.e., disease treatment). Leveraging in-depth market insights, zdeer is committed to medical solutions and, through substantial R&D investment, is progressively refining its product portfolio of comprehensive home health management solutions.

Healthy Living targets and resolves the minor health concerns of the majority—namely, general wellness and maintenance issues. Leveraging a robust technological moat in medical science, it further complements home health management solutions with proactive “wellness” and “care” measures, helping users build brand recognition for healthy living and strengthening brand perception among consumers.

Today, zdeer has established a comprehensive omnichannel presence across both online and offline platforms, enabling multi-point consumer engagement. Online, it covers traditional comprehensive e-commerce platforms such as Tmall and JD.com, while actively expanding into emerging e-commerce channels like Douyin and Kuaishou, as well as specialized healthcare e-commerce platforms including Ali Health and Dingxiang Doctor. Offline, it collaborates with numerous professional channels such as airport chain stores and large pharmacy chains, achieving continuous penetration at the channel level.

Recently, zdeer was selected for the "Forbes China Top 100 Emerging Brands" and the "2023 Future Healthcare 100 – China Innovative Medical Devices List," becoming a highly recognized innovative brand in smart technology-driven healthcare and healthy living.

zdeer has cultivated deep expertise in the medical and healthcare sector for many years, securing a significant first-mover advantage in product development. All of its core products possess independent intellectual property rights. By entering the market through technology-driven medical solutions, the company has continuously enhanced its R&D capabilities and technological barriers. It has filed nearly 3,000 independent patents and holds 14 Medical Device Registration Certificates issued by the People's Republic of China.

Furthermore, VCBeat has learned that in recent years, zdeer has cumulatively invested hundreds of millions of yuan in research and development (R&D). The company not only boasts an R&D team with extensive industry experience and has established a mature mechanism for R&D innovation, but has also set up dual R&D centers in Wuhan and Shenzhen, while independently building manufacturing facilities in Xuchang, Henan Province, and Changsha, Hunan Province. Its long-term investment in R&D within the medical technology sector has provided zdeer with robust quality control and strong technical support.

zdeer has been committed to providing users with more comprehensive health solutions, safeguarding them against various health issues throughout their entire life cycle. Zhu Jiangtao, the brand director of zdeer, stated, “The rapid development of the zdeer brand over the past decade is inseparable from our team’s consistent adherence to long-termism and our commitment to being ‘friends with time.’ zdeer has chosen the medical sector, where the core competitive barrier remains product strength. The medical sector is a field that requires long-term accumulation; one cannot always focus on making quick profits. Instead, we must solidly invest in research and development, continuously drive product innovation, and deepen market penetration.”